Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses

Affiliations

• ¹ Division of Rheumatology, 9007 St Gallen, Switzerland.
• ² Kantonsspital St Gallen, 9007 St Gallen, Switzerland.
• ³ Laboratory Medicine Division, Geneva University Hospitals, Geneva, Switzerland.
• ⁴ Division of Infectious Diseases and Hospital Epidemiology, 9007 St Gallen, Switzerland.
• ⁵ Institute of Immunobiology, 9007 St Gallen, Switzerland.
• ⁶ Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.